Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 40 citing articles:

The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Mette Kruse Klausen, Morgane Thomsen, Gitta Wörtwein, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 625-641
Open Access | Times Cited: 110
GLP-1: Molecular mechanisms and outcomes of a complex signaling system
Nicholas K. Smith, Troy A. Hackett, Aurelio Galli, et al.
Neurochemistry International (2019) Vol. 128, pp. 94-105
Open Access | Times Cited: 113
Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol
Candan Yasemin Eren, Arya Yigit, Ramazan Efe Dogruoz, et al.
Frontiers in Behavioral Neuroscience (2021) Vol. 14
Open Access | Times Cited: 72
The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies
Elisabet Jerlhag
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 37
IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target
Nicolaus Bruns, Elizabeth H. Tressler, Leandro F. Vendruscolo, et al.
Pharmacological Research (2024) Vol. 207, pp. 107312-107312
Open Access | Times Cited: 10
The association between glucose‐dependent insulinotropic polypeptide and/or glucagon‐like peptide‐1 receptor agonist prescriptions and substance‐related outcomes in patients with opioid and alcohol use disorders: A real‐world data analysis
Fares Qeadan, Ashlie McCunn, Benjamin Tingey
Addiction (2024)
Open Access | Times Cited: 8
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, et al.
Nature Mental Health (2025)
Open Access | Times Cited: 1
An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking
R. Merkel, Nicole S. Hernandez, Vanessa Weir, et al.
Science Advances (2025) Vol. 11, Iss. 9
Open Access | Times Cited: 1
Gut-brain axis and addictive disorders: A review with focus on alcohol and drugs of abuse
Elisabet Jerlhag
Pharmacology & Therapeutics (2018) Vol. 196, pp. 1-14
Open Access | Times Cited: 79
Effects of dulaglutide on alcohol consumption during smoking cessation
Leila Probst, Sophie Monnerat, D. Vogt, et al.
JCI Insight (2023) Vol. 8, Iss. 22
Open Access | Times Cited: 20
Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents
Daniel Vallöf, Aimilia Lydia Kalafateli, Elisabet Jerlhag
Psychoneuroendocrinology (2019) Vol. 103, pp. 284-295
Open Access | Times Cited: 52
GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence
Elisabet Jerlhag
Neuropharmacology (2018) Vol. 136, pp. 343-349
Open Access | Times Cited: 46
Central GLP-1 receptors: Novel molecular targets for cocaine use disorder
Nicole S. Hernandez, Heath D. Schmidt
Physiology & Behavior (2019) Vol. 206, pp. 93-105
Open Access | Times Cited: 42
Glucagon-like peptide-1 receptors within the nucleus of the solitary tract regulate alcohol-mediated behaviors in rodents
Daniel Vallöf, Jesper Vestlund, Elisabet Jerlhag
Neuropharmacology (2019) Vol. 149, pp. 124-132
Open Access | Times Cited: 39
Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder
Gustavo A. Angarita, David Matuskey, Brian Pittman, et al.
Drug and Alcohol Dependence (2021) Vol. 221, pp. 108614-108614
Open Access | Times Cited: 31
The pleiotropic of GLP-1/GLP-1R axis in central nervous system diseases
Longqing Zhang, Wen Zhang, Xuebi Tian
International Journal of Neuroscience (2021) Vol. 133, Iss. 5, pp. 473-491
Closed Access | Times Cited: 28
An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking
R. Merkel, Nicole S. Hernandez, Vanessa Weir, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Utilization of Data Below the Analytical Limit of Quantitation in Pharmacokinetic Analysis and Modeling: Promoting Interdisciplinary Debate
Max Hecht, Rūta Veigure, Lewis Couchman, et al.
Bioanalysis (2018) Vol. 10, Iss. 15, pp. 1229-1248
Open Access | Times Cited: 28
An Overview of Appetite-Regulatory Peptides in Addiction Processes; From Bench to Bed Side
Olesya T. Shevchouk, Maximilian Tufvesson‐Alm, Elisabet Jerlhag
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 23
Animal studies reveal that the ghrelin pathway regulates alcohol-mediated responses
Elisabet Jerlhag
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 9
Cocaine and cocaine expectancy increase growth hormone, ghrelin, GLP-1, IGF-1, adiponectin, and corticosterone while decreasing leptin, insulin, GIP, and prolactin
Zhi‐Bing You, Bin Wang, Eliot L. Gardner, et al.
Pharmacology Biochemistry and Behavior (2018) Vol. 176, pp. 53-56
Closed Access | Times Cited: 27
An amylin analogue attenuates alcohol-related behaviours in various animal models of alcohol use disorder
Aimilia Lydia Kalafateli, Daniel Vallöf, Giancarlo Colombo, et al.
Neuropsychopharmacology (2019) Vol. 44, Iss. 6, pp. 1093-1102
Open Access | Times Cited: 24
Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral β1 receptors
Zhi‐Bing You, Ewa Galaj, Francisco Alén, et al.
Neuropsychopharmacology (2021) Vol. 47, Iss. 8, pp. 1449-1460
Open Access | Times Cited: 18
Feasibility of Exenatide, a GLP-1R Agonist, for Treating Cocaine Use Disorder: A Case Series Study
Luba Yammine, Jessica Balderas, Michael F. Weaver, et al.
Journal of Addiction Medicine (2023) Vol. 17, Iss. 4, pp. 481-484
Closed Access | Times Cited: 7
Leptin Protects Against the Development and Expression of Cocaine Addiction-Like Behavior in Heterogeneous Stock Rats
Lieselot L. G. Carrette, C. Cano Corral, Brent Boomhower, et al.
Frontiers in Behavioral Neuroscience (2022) Vol. 16
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top